EUVIMEDEUVIMED entdecken
Crossref

2951-LB: MiRNA Abundance in Mesenchymal Stem Cells Exposed to Diabetes In Utero

WAI HAN LEE, MARTA ONOPIUK, BENJAMIN NELSON, JACOB FRIEDMAN, SARAH J. BORENGASSER, JEANIE TRYGGESTAD

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2951-lb ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von WAI HAN LEE und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Mesenchymal stem cells (MSCs) from infants born to mothers with obesity and diabetes demonstrate increased adipogenic capacity, but the molecular mechanisms underlying this effect are unclear. The objective was to quantify changes in miRNA abundance in MSCs resulting from diabetes exposure and map their potential downstream pathways.

Methods

Pregnant persons, 18 control and 17 with diabetes, either GDM or T2D, presenting for elective caesarian section at term were recruited. The diagnosis of GDM or T2D was based on prevailing criteria. Type 1 diabetes, preeclampsia, or chronic hypertension were exclusions. MSCs were isolated from umbilical cord Wharton’s jelly using the “explant culture” method. RNA was extracted using miRNeasy kit. nCounter Human v3 miRNA Panel (NanoString Technologies) was used for miRNA profiling. Raw gene counts were normalized by log2 counts-per-million. Transformed data were fit to linear models using generalized least squares, and a moderated t-statistic was computed using empirical Bayes methods. Results were considered significant if log2 fold change ± 0.5 and p-value < 0.05 after controlling for birthweight, gestational age, maternal age, and pre-pregnancy BMI. Pathway analysis utilized mRNA targets of the miRNAs (validated in 2 databases) with an adjusted p-value < 0.05. Results: miR-548e-3p, miR-579-3p, and miR-1180-3p demonstrated lower abundance in the MSCs exposed to maternal diabetes (fold change -1.76, -0.74 and -0.55; p-value 0.020, 0.032, and 0.017, respectively). GO analysis showed enrichment of histone modification and programmed cell death (apoptotic) signaling pathways (24-34-fold enrichment, p<0.03). From Reactome analysis, BMAL1:CLOCK activation and cholesterol biosynthesis pathways were enriched (15-44-fold enrichment, p<0.05).

Conclusion

Specific differences in miRNA abundance, leading to circadian rhythm and epigenetic modifications, may be mechanisms underlying increased adipogenesis thereby placing offspring at risk for obesity and future metabolic disease. Disclosure W. Lee: None. M. Onopiuk: None. B. Nelson: None. J. Friedman: None. S.J. Borengasser: None. J. Tryggestad: Research Support; Current; Abbott Diabetes. Other - Site PI for study; Current; Ascendis Pharma A/S, Lilly Diabetes. Funding Harold Hamm Diabetes Center Team Science Grant

Zitieren

APA

LEE, W. H., ONOPIUK, M., NELSON, B., FRIEDMAN, J., BORENGASSER, S. J., & TRYGGESTAD, J. (2026). 2951-LB: MiRNA Abundance in Mesenchymal Stem Cells Exposed to Diabetes In Utero. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2951-lb

Vancouver

LEE WH, ONOPIUK M, NELSON B, FRIEDMAN J, BORENGASSER SJ, TRYGGESTAD J. 2951-LB: MiRNA Abundance in Mesenchymal Stem Cells Exposed to Diabetes In Utero. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2951-lb

BibTeX
@article{LEE2026,
  author = {LEE, WAI HAN and ONOPIUK, MARTA and NELSON, BENJAMIN and FRIEDMAN, JACOB and BORENGASSER, SARAH J. and TRYGGESTAD, JEANIE},
  title = {2951-LB: MiRNA Abundance in Mesenchymal Stem Cells Exposed to Diabetes In Utero},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2951-lb}
}
Kostenlos starten →